Stockscreener 앱 받기
3.19
0.93%
-0.03
전일 마감가:
$3.22
열려 있는:
$3.22
하루 거래량:
201.81K
Relative Volume:
0.75
시가총액:
$106.47M
수익:
-
순이익/손실:
$-12.48M
주가수익비율:
-8.1795
EPS:
-0.39
순현금흐름:
$-7.93M
1주 성능:
-5.62%
1개월 성능:
-10.64%
6개월 성능:
-5.06%
1년 성능:
+23.64%
1일 변동 폭
$3.166
$3.2798
1주일 범위
$3.07
$3.39
52주 변동 폭
$2.331
$5.4566
Anixa Biosciences Inc Stock (ANIX) Company Profile
명칭
Anixa Biosciences Inc
전화
408-708-9808
주소
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
ANIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
3.19 | 107.47M | 0 | -12.48M | -7.93M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 개시 | Maxim Group | Buy |
| 2022-12-23 | 개시 | Chardan Capital Markets | Buy |
| 2021-04-12 | 개시 | H.C. Wainwright | Buy |
Anixa Biosciences Inc 주식(ANIX)의 최신 뉴스
Anixa Biosciences Inc (NASDAQ:ANIX) Short Interest Update - MarketBeat
Anixa Biosciences (NASDAQ:ANIX) Rating Increased to Hold at Wall Street Zen - MarketBeat
ANIX: D. Boral Capital Maintains Buy Rating with $10 Price Targe - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Issues Earnings Results, Meets Expectations - MarketBeat
Breakouts Watch: Will Anixa Biosciences Inc stock attract ESG investorsWeekly Stock Recap & Free Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Anixa Biosciences : Annual Report for Fiscal Year Ending October 31, 2025 (Form 10-K) - marketscreener.com
Anixa Biosciences Inc SEC 10-K Report - TradingView — Track All Markets
Published on: 2026-01-11 17:33:32 - Улправда
ETF Watch: Will Anixa Biosciences Inc. stock deliver better than expected guidanceJuly 2025 Short Interest & Risk Adjusted Buy and Sell Alerts - Улправда
Why Anixa Biosciences Inc. stock appeals to dividend seekersWeekly Earnings Recap & Stock Timing and Entry Methods - Улправда
What catalysts could drive Anixa Biosciences Inc. stock higherWeekly Trade Recap & Verified Entry Point Detection - Улправда
Why analysts upgrade Anixa Biosciences Inc. stockStock Buyback Updates & Low Risk Trading Portfolio - Улправда
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Anixa Biosciences (ANIX) Expected to Announce Quarterly Earnings on Friday - MarketBeat
Anixa announces transfer of IND for breast cancer vaccine from Cleveland Clinic - MSN
Anixa Biosciences Inc (NASDAQ:ANIX) Sees Significant Increase in Short Interest - MarketBeat
Anixa Biosciences director Titterton buys $8,820 in common stock - MSN
Anixa Biosciences (STU:CY71) EV-to-OCF : -12.38 (As of Dec. 28, 2025) - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Anixa Biosciences (FRA:CY71) EV-to-OCF : -12.43 (As of Dec. 22, 2025) - GuruFocus
Can Anixa Biosciences Inc. stock attract ESG capital inflowsMarket Sentiment Review & Low Drawdown Trading Techniques - Улправда
Is Anixa Biosciences Inc. stock gaining market shareEarnings Recap Report & AI Enhanced Trading Signals - Улправда
Why retail investors pile into Anixa Biosciences Inc. stock2025 Market Overview & Safe Capital Preservation Plans - Улправда
Is Anixa Biosciences Inc. (CY71) stock a buy for dividend portfolios2025 Macro Impact & Fast Exit Strategy with Risk Control - DonanımHaber
ANIX: Phase 1 Breast Cancer Vaccine Success Paves Way for Program Advancement - Smartkarma
Will Anixa Biosciences Inc. stock deliver better than expected guidanceJuly 2025 Selloffs & Capital Protection Trade Alerts - DonanımHaber
Gap Down: Is Anixa Biosciences Inc CY71 stock cheap by valuation metricsNew Guidance & Target Return Focused Stock Picks - moha.gov.vn
What is the fair value of Anixa Biosciences Inc. stock now2025 EndofYear Setup & Fast Gain Swing Alerts - Улправда
How strong is Anixa Biosciences Inc. stock balance sheetWeekly Profit Summary & Growth Focused Stock Pick Reports - Улправда
Aug Action: Why Anixa Biosciences Inc stock could be next big winnerMarket Movers & Fast Momentum Entry Tips - moha.gov.vn
Anixa Biosciences Inc (ANIX) director reports 16,000 share option exercise - Stock Titan
Anixa Biosciences takes over breast cancer vaccine IND from Cleveland Clinic - Investing.com Australia
Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History - Yahoo Finance
ANIX: Breast cancer vaccine phase I showed 75% robust immune response and strong safety profile - TradingView — Track All Markets
Anixa Biosciences falls on phase 1 data for breast cancer vaccine - MSN
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 - WV News
Cleveland Clinic transfers breast cancer vaccine IND to Anixa - marketscreener.com
Anixa Biosciences (ANIX) Advances Breast Cancer Vaccine Developm - GuruFocus
Anixa Biosciences Announces Transfer of IND for Breast Cancer Va - GuruFocus
Anixa Biosciences takes over breast cancer vaccine IND from Cleveland Clinic By Investing.com - Investing.com South Africa
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic - Nasdaq
D. Boral Capital Maintains Anixa Biosciences (ANIX) Buy Recommendation - Nasdaq
Anixa Biosciences (ANIX) Shares Drop 21% After Phase 1 Vaccine D - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at D. Boral Capital - MarketBeat
Anixa Biosciences Reports Positive Phase 1 Trial Results - TipRanks
Anixa Biosciences Inc Announces Positive Phase 1 Data for Breast Cancer Vaccine - TradingView — Track All Markets
Anixa Biosciences Says Breast Cancer Vaccine Candidate Meets Key Endpoints in Phase 1 Trial - marketscreener.com
Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why - Benzinga
Anixa Biosciences Announces Positive Phase 1 Data for Investigat - GuruFocus
Anixa Biosciences (ANIX) Presents Promising Phase 1 Breast Cance - GuruFocus
Anixa Biosciences (NASDAQ: ANIX) presents final Phase 1 breast cancer vaccine data - Stock Titan
Anixa Biosciences Inc (ANIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Anixa Biosciences Inc 주식 (ANIX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| KUMAR AMIT | Chief Executive Officer |
Oct 30 '25 |
Option Exercise |
2.92 |
200,000 |
584,000 |
779,925 |
| Titterton Lewis H jr | Director |
Jul 31 '25 |
Buy |
3.08 |
10,000 |
30,800 |
953,334 |
| KUMAR AMIT | Chief Executive Officer |
Jul 30 '25 |
Buy |
3.16 |
5,000 |
15,800 |
579,925 |
| Baskies Arnold M | Director |
Jul 18 '25 |
Buy |
3.39 |
5,000 |
16,950 |
125,000 |
| Titterton Lewis H jr | Director |
Jul 11 '25 |
Buy |
3.14 |
10,000 |
31,400 |
943,334 |
| KUMAR AMIT | Chief Executive Officer |
Jul 11 '25 |
Buy |
3.15 |
5,000 |
15,750 |
574,925 |
| KUMAR AMIT | Chief Executive Officer |
Jun 04 '25 |
Buy |
2.85 |
10,000 |
28,500 |
569,925 |
| Baskies Arnold M | Director |
Jan 28 '25 |
Buy |
2.82 |
5,000 |
14,100 |
120,000 |
| Titterton Lewis H jr | Director |
Jan 23 '25 |
Buy |
2.91 |
2,000 |
5,820 |
932,334 |
| Titterton Lewis H jr | Director |
Jan 24 '25 |
Buy |
3.00 |
1,000 |
3,000 |
933,334 |
4.73%
0.92%
자본화:
|
볼륨(24시간):